Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 85

1.

Association of factor XII gene C46T polymorphism with cerebral venous thrombosis in the south Indian population.

Prabhakar P, De T, Nagaraja D, Christopher R.

J Thromb Haemost. 2012 Jul;10(7):1437-9. doi: 10.1111/j.1538-7836.2012.04743.x. No abstract available.

2.

Factor XII C46T gene polymorphism and the risk of cerebral venous thrombosis.

Reuner KH, Jenetzky E, Aleu A, Litfin F, Mellado P, Kloss M, Jüttler E, Grau AJ, Rickmann H, Patscheke H, Lichy C.

Neurology. 2008 Jan 8;70(2):129-32. doi: 10.1212/01.wnl.0000296825.05176.da.

PMID:
18180442
3.

About the significance or the insignificance of the factor XII C46T polymorphism: a rebuttal.

Girolami A, Vettore S, Lombardi AM.

J Thromb Haemost. 2007 Oct;5(10):2162-3; authors reply 2163-5. No abstract available.

4.

Coagulation factor VII R353Q polymorphism and the risk of puerperal cerebral venous thrombosis.

Kruthika-Vinod TP, Nagaraja D, Christopher R.

J Clin Neurosci. 2012 Jan;19(1):190-1. doi: 10.1016/j.jocn.2011.05.029. Epub 2011 Dec 1.

PMID:
22136731
5.

The 46C-->T polymorphism in the factor XII gene (F12) and the risk of venous thrombosis.

Bertina RM, Poort SR, Vos HL, Rosendaal FR.

J Thromb Haemost. 2005 Mar;3(3):597-9. No abstract available.

6.

Factor XII gene (F12) -4C/C polymorphism in combination with low protein S activity is associated with deep vein thrombosis.

Kanaji T, Watanabe K, Hattori S, Urata M, Iida H, Kinoshita S, Kayamori Y, Kang D, Hamasaki N.

Thromb Haemost. 2006 Dec;96(6):854-5. No abstract available.

PMID:
17139385
7.

Haemostatic proteins gene polymorphisms in patients with unusual vein thrombosis and Ph-myeloproliferative disorders.

Randi ML, Lombardi AM, Scapin M, Tezza F, Scandellari R, Ruzzon E, Duner E, Fabris F.

Thromb Haemost. 2007 Sep;98(3):702-4. No abstract available.

PMID:
17849070
8.

Rebuttal: factor XII levels, factor XII 46 C>T polymorphism and venous thrombosis: a word of caution is needed.

Girolami A, Sartori MT, Lombardi AM, Pellati D.

Thromb Haemost. 2004 Oct;92(4):892-3; author reply 894-5. No abstract available.

PMID:
15467923
9.

The prothrombin gene G20210A variant and puerperal cerebral venous and sinus thrombosis in South Indian women.

Nagaraja D, Kruthika-Vinod TP, Christopher R.

J Clin Neurosci. 2007 Jul;14(7):635-8. Epub 2007 Apr 12.

PMID:
17433691
10.

Thrombophilic polymorphisms - factor V Leiden G1691A, prothrombin G20210A and MTHFR C677T - in Tunisian patients with cerebral venous thrombosis.

Ben Salem-Berrabah O, Fekih-Mrissa N, N'siri B, Ben Hamida A, Benammar-Elgaaied A, Gritli N, Mrissa R.

J Clin Neurosci. 2012 Sep;19(9):1326-7. doi: 10.1016/j.jocn.2011.11.029. Epub 2012 Jun 20.

PMID:
22721898
11.

[Mutation of the prothrombin gene (G20210A) in a patient with cerebral venous sinus thrombosis and bilateral deep vein thrombosis].

Ortín X, Ugarriza A, Escoda L, Mesa R.

Med Clin (Barc). 2004 Feb 7;122(4):158. Spanish. No abstract available.

PMID:
14967101
12.

The C46T polymorphism of the coagulation factor XII gene and idiopathic recurrent miscarriage.

Walch K, Riener EK, Tempfer CB, Endler G, Huber JC, Unfried G.

BJOG. 2005 Oct;112(10):1434-6.

13.

The V617F JAK 2 mutation is not a frequent event in patients with cerebral venous thrombosis without overt chronic myeloproliferative disorder.

Bellucci S, Cassinat B, Bonnin N, Marzac C, Crassard I.

Thromb Haemost. 2008 Jun;99(6):1119-20. doi: 10.1160/TH08-02-0081. No abstract available.

PMID:
18521518
14.

Paternal endothelial protein C receptor 219Gly variant as a mild and limited risk factor for deep vein thrombosis during pregnancy.

Galanaud JP, Cochery-Nouvellon E, Alonso S, Chauleur C, Mercier E, Lissalde-Lavigne G, Fabbro-Peray P, Reny JL, Mares P, Dauzat M, Quere I, Gris JC.

J Thromb Haemost. 2010 Apr;8(4):707-13. doi: 10.1111/j.1538-7836.2010.03770.x. Epub 2010 Feb 6.

15.

No association of the plasma glutathione peroxidase (GPx-3) gene with cerebral venous thrombosis in the German population.

Grond-Ginsbach C, Arnold ML, Lichy C, Grau A, Reuner K.

Stroke. 2009 Feb;40(2):e24; author reply e25. doi: 10.1161/STROKEAHA.108.540062. Epub 2008 Dec 18. No abstract available.

16.

The functional -4C>T polymorphism of the coagulation factor XII gene is not associated with deep venous thrombosis.

Grünbacher G, Marx-Neuhold E, Pilger E, Köppel H, Renner W.

J Thromb Haemost. 2005 Dec;3(12):2815-7. No abstract available.

17.

The JAK2 V617F mutation in patients with cerebral venous thrombosis: a rebuttal.

De Stefano V, Rossi E, Za T, Chiusolo P, Leone G.

Thromb Haemost. 2008 Jun;99(6):1121. doi: 10.1160/TH08-04-0205. No abstract available.

PMID:
18521519
18.

Antithrombin Cambridge II mutation as a risk factor to develop cerebral venous thrombosis.

Barba P, Santamaría A, Tirado I, Martí E, Fontcuberta J.

Thromb Haemost. 2008 Feb;99(2):443-4. doi: 10.1160/TH07-11-0670. No abstract available.

PMID:
18278198
19.

Prothrombin G20210A mutation, and not factor V Leiden mutation, is a risk factor for cerebral venous thrombosis in Brazilian patients.

Rodrigues CA, Rocha LK, Morelli VM, Franco RF, Lourenço DM.

J Thromb Haemost. 2004 Jul;2(7):1211-2. No abstract available.

20.

MTHFR and the risk for cerebral venous thrombosis--a meta-analysis.

Gouveia LO, Canhão P.

Thromb Res. 2010 Apr;125(4):e153-8. doi: 10.1016/j.thromres.2009.10.019. Epub 2009 Nov 18.

PMID:
19926119

Supplemental Content

Support Center